| Literature DB >> 15304365 |
Delia Recalde1, Nadine Baroukh, Celine Viglietta, Sonia Prince, Julián Verona, Laurent Vergnes, Josette Pidoux, M Nazeem Nanjee, Fernando Brites, Alberto Ochoa, Graciela Castro, Mario M Zakin, Norman E Miller, Louis Marie Houdebine.
Abstract
We have generated transgenic rabbits that express the entire human apoA-I/C-III/A-IV gene cluster. As in humans, h-apoA-I and h-apoC-III were expressed in liver and intestine, whereas h-apoA-IV mRNA was detected in intestine only. Transgenic rabbits had significantly higher plasma total cholesterol, HDL-cholesterol and total phospholipid concentrations than non-transgenic littermates. In contrast to similar transgenic mice previously generated, which have gross hypertriglyceridemia, triglyceride concentrations were only moderately raised in transgenic rabbits. Plasma and HDL from transgenic rabbits were more effective than those from controls in promoting cholesterol efflux from cultured hepatoma cells. They had lower LCAT, lower CETP and higher PLTP activities than non-transgenic littermates. Cholesterol-feeding produced major increases in plasma lipids. The qualitative response to the diet was not modified by cluster expression. Human apoA-I concentration was halved by cholesterol-feeding, whereas h-apoC-III and h-apoA-IV concentrations were not significantly altered. Cholesterol efflux from hepatoma cells to plasma and HDL was not altered by the diet. Since lipoprotein metabolism of rabbits closely resembles that of humans, human apoA-I/C-III/A-IV transgenic rabbits may provide a reliable model for studies of the transcriptional regulation of the cluster, and for evaluating the effects of different agents on the expression of the three genes.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15304365 DOI: 10.1016/j.febslet.2004.07.041
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124